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Abstract
Background Most of the lymphomas arising in the oral
cavity are of B-cell origin. Among these, diffuse large B-
cell lymphomas are the most common. Diffuse large B-cell
lymphomas may exhibit more than one chromosomal
rearrangement and are then referred to as ‘double-hit’ or
‘triple-hit’ lymphomas.
Case report We present a case of an intraoral ‘double-hit’
lymphoma in a 76-year-old male who had been referred by
an oral surgeon in private practice. Intraoral examination
exhibited a firm, exophytic lesion in the region of the right
hard palate and buccal mucosa with extension to the soft
palate. Radiographic examination exhibited a massive
thickening of the right sinus membrane, and arrosion of
the lateral and basal cortical sinus walls in the right maxilla.
After diagnosis of the lesion, the patient was treated with
six cycles of chemotherapy.
Discussion Lymphomas arising within the oral cavity
account for less than 5% of all oral malignancies and typically
affect the palatine tonsils and the palate. ‘Double-hit’
lymphomas are associated with older age, usually present with
an advanced stage of disease, and show an aggressive clinical
behaviour. They normally have a poor prognosis, even when
treated with intensive chemotherapy regimens. Nevertheless,
in the case presented, the patient was free of symptoms 1 year
after initial diagnosis.
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Introduction
Lymphomas are a heterogeneous group of malignant
neoplasms of lymphocytes and their precursor cells. They
are traditionally subdivided into Hodgkin’s lymphomas
and non-Hodgkin lymphomas according to their histology
and patterns of behaviour. Hodgkin’s lymphoma is histo-
logically characterised by the presence of Hodgkin– and
Reed–Sternberg cells, and clinically often presents as nodal
disease, with a predilection for neck and mediastinal lymph
nodes. All other neoplasms of the lymphoid system are
called non-Hodgkin lymphomas (NHLs) and are further
subdivided according to the World Health Organisation
(WHO) classification of haematopoietic and lymphoid
neoplasms [1].
In contrast to Hodgkin’s lymphoma, NHLs have a
propensity to disseminate to extranodal locations. These
tissues are quite diverse in type and region, including
stomach, skin, lung, central nervous system, orbit, salivary
glands and the oral cavity [2]. Up to 40% of NHL present at
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an extranodal site [3], with 2% to 3% of these extranodal
NHL cases first arising in the oral mucosa and jaws [2, 4].
Oropharyngeal lymphomas are the second most common
malignant disease in the oral region, after squamous cell
carcinoma [5], and the most frequent non-epithelial
malignant neoplasia in the maxillofacial region [6]. They
generally occur in the Waldeyer’s tonsillar ring (pharyngeal
tonsil or tubal tonsil). Lymphomas arising within the oral
cavity account for less than 5% of all oral malignancies [5, 7]
and typically affect the palatine tonsils and the palate [7–9].
To the best of our knowledge, the following case
presentation describes and discusses the first manifestation
of an intraoral ‘double-hit’ lymphoma, an entity in which a
diffuse large B-cell lymphoma exhibits two distinct
chromosomal rearrangements.
Case report
The patient, a 76-year-old male who had been a pipe smoker
for 22 years, was referred to the Department of Oral Surgery
and Stomatology by an oral surgeon in private practice. The
patient had been referred to the oral surgeon by the nursing
home staff. During the last few months, swelling of the right
buccal plane and palate had developed, and the patient had
started to complain because his upper denture did not fit
anymore. His medical history included several cardiovascular
risk factors: hypertensive cardiopathy, insulin-independent
diabetes mellitus with renal insufficiency, and obesity.
At the initial examination, the patient was afebrile,
without any palpable lymph nodes in the head and neck
region, and he did not mention any recent weight loss. He
reported only a little pain when the tumour was pressed.
Clinically, the right side of his face was slightly asymmetric
and swollen. Intraoral examination exhibited a firm,
exophytic lesion in the region of the right hard palate and
buccal mucosa, with extension to the soft palate. The
mucosal surface of the mass was slightly red but not
particularly noticeable (Fig. 1). Hypoesthesia in the second
branch of the trigeminal nerve was recorded. Surprisingly,
the full upper denture had been shaped and adapted around
the tumour (Fig. 2). The patient reported that he had visited
a dental technician after the swelling had become estab-
lished because of mismatch and pain due to the upper
denture.
Limited cone beam computed tomography (CBCT; field of
view=6×6 cm; 3D Accuitomo XYZ Slice View Tomograph,
J. Morita) was performed to detect potential destruction of the
underlying maxillary bone in the area. In the corresponding
CBCT slices, a massive thickening of the right sinus
membrane could be observed. The images also showed
arrosion of the lateral and basal cortical sinus walls in the
right maxilla (Fig. 3).
Based on these clinical and radiographic findings, a
malignant process was suspected. Therefore, the patient
was immediately referred to the interdisciplinary tumour
board of the Department of ENT, Head and Neck Surgery at
the University Hospital of Bern for further diagnostic
procedures. A computed tomography (CT) scan was
performed, and the patient was hospitalised. A biopsy of
the tumorous mass on the buccal mucosa was taken, and
endoscopy of all paranasal sinuses was performed.
The histopathologic examination (Fig. 4a, b) of the
biopsy showed massive infiltrates of blast-like lymphoid
cells with high proliferative activity (90%) invading the
skeletal muscle. The tumour cells demonstrated the charac-
teristic morphology of B-blasts, with large, irregularly
contoured nuclei with mostly one centrally placed nucleo-
lus (Fig. 4c, d). No starry-sky pattern, as observed in
Burkitt lymphoma, could be detected. The immunohisto-
chemical analysis revealed a positive reaction for the B-cell
markers CD20, CD79a and Pax-5 and co-expression of
CD10 and BCL-2 (from B-cell lymphoma 2, the second
Fig. 1 Initial clinical aspect of the exophytic, painless mass in the
region of the right hard palate and buccal mucosa
Fig. 2 Right aspect of the denture with clearly reduced margins due
to the tumorous mass
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member of a range of proteins initially described in
follicular lymphomas that play a role in decreased apopto-
sis), while there was only a weak positivity for BCL-6. The
tumour cells did not stain for MUM-1. Due to the high
proliferative index, the positivity for BCL-6 and CD10, and
the negativity for MUM-1, the possibility of a ‘double-hit’
was considered and the probe underwent further analyses.
In a fluorescence in situ hybridisation (FISH), breaks at the
BCL-6 and cMYC loci, but not the BCL-2 locus, were
detected. Thus, the tumour was classified as a ‘double-hit’
diffuse large B-cell lymphoma. The complete staging
revealed a stage IIIA with infiltration of the upper pole of
the right kidney. The patient then received six cycles of R-
CHOP chemotherapy, a combination of a CHOP regimen
(cyclophosphamide, hydroxydaunorubicin, oncovin and
prednisone) with the monoclonal CD20-antibody rituxi-
mab. He received one cycle every 3 weeks. After four
cycles, a CT scan was taken, showing complete remission
of the tumour. A residual facial nerve palsy on the right side
was noticed. In the hard palate, a soft tissue lesion with
exposure of underlying bone was visible (Fig. 5). Because
of the total absence of symptoms, no surgical revision was
initiated, and the patient was instructed in the use of a
chlorhexidine gel for local disinfection of the wound
region. One year following initial diagnosis, the patient
remains in our care, with visits scheduled every 4 to
6 months.
Discussion
Extranodal NHLs can affect patients of all ages, but the
peak incidence is between 60 and 70 years of age. The
NHLs show a predilection for the maxilla, including the
soft tissues of the palate. No gender predilection can be
observed in affected patients [10, 11]. NHLs can be
grouped in subtypes based on their histologic pattern,
cellular morphology and immunohistochemical staining.
The WHO classification of haematopoietic and lymphoid
neoplasms aims at combining the clinical aspects, histo-
morphological features, immunohistochemical phenotype
and genetic features [1]. The aggressive diffuse large B-cell
lymphoma (DLBCL) is reported to account for 50% to 68%
of all non-Hodgkin lymphomas [12]. The 5-year overall
Fig. 3 Coronal (a, b), sagittal
(c) and horizontal (d) CBCT
slices depict swelling in the right
maxillary sinus and erosion
of the lateral cortical sinus
wall
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survival rate depends on the stage of the tumour at
diagnosis, and is reported to be around 50% [13].
Therefore, early diagnosis is imperative.
Regarding the reduced margins of the denture in the case
presented, the tumour mass seems to have been present and
growing for quite some time before diagnosis. It can be
speculated that the NHL could have been diagnosed earlier
if the patient had visited a dentist instead of a dental
technician [14]. In the present case, it was not possible to
exactly determine the delay in diagnosis, as the patient
could not remember when he initially went to see the dental
technician or how often he returned. This case report
illustrates the necessity of regular screening of edentulous
patients by a trained dentist. However, case reports like this
seem to be rare [15].
Patients with intraoral lymphoma often present with non-
specific radiological and clinical signs such as obstruction
of paranasal sinuses in radiographic images and swelling or
Fig. 5 Residual soft tissue lesion with exposure of underlying bone in
the palate
Fig. 4 Incisional biopsy of the tumourous mass. a Overview of the
lesion, with squamous epithelium covering the lymphoma infiltrates. b
Proliferation of blasts at a higher magnification. Note the classic
blastic appearance of the neoplastic cells, with round and vesicular
nuclei and mostly one centrally placed nucleolus. c Immunostaining
for CD20. All neoplastic cells show a strong membranous staining
pattern for CD20. d Immunostaining for Mib-1. The proliferation
index is about 90%
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ulceration of the mucosa. Initially, the lesions are often
mistaken for inflammatory or reactive processes. As
differential diagnoses, squamous cell carcinoma and benign
or malignant neoplasias of palatal salivary glands should
also be excluded, ideally with an incisional biopsy [16].
The most common chromosomal rearrangement in
diffuse large B-cell lymphoma is the BCL-6 translocation
(up to 30%), followed by BCL-2 rearrangements (20–30%)
and MYC rearrangements (up to 10%). So-called double-hit
lymphomas exhibit two chromosomal rearrangements [17].
Based on morphological, immunohistochemical and genetic
findings, these tumours can be classified as ‘double-hit’
diffuse large B-cell lymphomas or as ‘B-cell lymphoma,
unclassifiable, with features between diffuse large B-cell
lymphoma and Burkitt lymphoma’. The latter entity was
introduced by the 2008 WHO Classification of Tumors of
Haematopoietic and Lymphoid Tissues together with
another new entity called ‘B-cell lymphoma, unclassifiable,
with features between diffuse large B-cell lymphoma and
classical Hodgkin lymphoma’ [18, 19]. These lymphomas
are also referred to as ‘grey-zone lymphomas’. In the present
case, the differential diagnosis of a ‘B-cell lymphoma,
unclassifiable, with features intermediate between diffuse large
B-cell lymphoma and Burkitt lymphoma’ was considered.
However, the typical morphology of the blasts, the strong
positivity for BCL-2 and the only weak positivity for BCL-6
were in favour of the diagnosis of a ‘double-hit’ diffuse large
B-cell lymphoma.
‘Double-hit’ lymphomas involving a rearrangement of both
the MYC and the BCL-6 gene loci show a more aggressive
clinical behaviour and usually present with an advanced stage
of disease. They normally have a poor prognosis, even when
treated with intensive chemotherapy regimens [20, 21]. The
reason for the aggressive behaviour is the overexpression of
pro-proliferative (MYC) and anti-apoptotic (BCL2, BCL6)
oncoproteins at the same time. To the best of our knowledge,
this case presented describes and discusses the first manifes-
tation of an intraoral double-hit lymphoma.
Conclusion
The present case report of diffuse swelling of the buccal
mucosa and palate as the first and only manifestation of an
extranodal non-Hodgkin ‘double-hit’ lymphoma in a 76-year-
old patient shows the need for immediate and accurate
diagnostic procedures, including immunohistochemical analy-
sis, to avoid delay and inappropriate treatment strategies.
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